1-7 of 7
David J. King
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1824: Discovery and evaluation of an anti-IL18BP antibody to enhance anti-tumor immunity

H. Toni Jun, Deborah A. Witherden, Eric K. Elliot, Christine M. Chidester, Maggie Willen, Bryan R. Peguero, Merrick Chai, Robert A. Horlick, David J. King
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 1824.
https://doi.org/10.1158/1538-7445.AM2023-1824
Published: 04 April 2023
View article titled, Abstract 1824: Discovery and evaluation of an anti-IL18BP antibody to enhance anti-tumor immunity
Journal Articles

Abstract 3834: Antibodies targeting Resokine, a soluble immune modulator, inhibit tumor growth in syngeneic mouse models

Kathy Ogilvie, Cherie Ng, Leslie Nangle, Jeanette Ampudia, Joon Chang, Andrea Cubitt, David J. King, John Mendlein
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 3834.
https://doi.org/10.1158/1538-7445.AM2018-3834
Published: 01 July 2018
View article titled, Abstract 3834: Antibodies targeting Resokine, a soluble immune modulator, inhibit tumor growth in syngeneic mouse models
Journal Articles

Abstract 271: Targeting PD-1, TIM-3 and LAG-3 in combination for improved immunotherapy combinations

Marilyn Kehry, Robert Horlick, Peter Bowers, Toni Jun, Jean da Silva Correia, Jonathan Graves, Yan Wang, Haley Laken, David J. King
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 271.
https://doi.org/10.1158/1538-7445.AM2015-271
Published: 01 August 2015
View article titled, Abstract 271: Targeting PD-1, TIM-3 and LAG-3 in combination for improved immunotherapy combinations
Journal Articles

Human antibody conjugates of DNA minor groove-binding alkylating agents with single dose efficacy in xenograft models which retain activity in drug resistant cells

Chin Pan, Sanjeev Gangwar, Liang Chen, Chetana Rao, Mary Huber, Peter Sattari, Mary Do, Rory Dai, Colin Chong, Carol Soderberg, Hao Li, Bilal Sufi, Sharon Boyd, Haichun Huang, Haibin Chen, Vincent Guerlavais, Killian Horgan, Nik Sharkov, Pina Cardarelli, David J. King
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 277.
Published: 15 April 2006
View article titled, Human antibody conjugates of DNA minor groove-binding alkylating agents with single dose efficacy in xenograft models which retain activity in drug resistant cells
Journal Articles

CD10 Is a Key Enzyme Involved in the Activation of Tumor-activated Peptide Prodrug CPI-0004Na and Novel Analogues: Implications for the Design of Novel Peptide Prodrugs for the Therapy of CD10+ Tumors

Chin Pan, Pina M. Cardarelli, Matthew H. Nieder, Lesley B. Pickford, Sanjeev Gangwar, David J. King, Geoffrey T. Yarranton, Dana Buckman, William Roscoe, Fengmin Zhou, Adam Salles, Tseng-Hui Chen, Killian Horgan, Yi-Hong Wang, Thi Nguyen, Christopher R. Bebbington
Journal: Cancer Research
Cancer Res (2003) 63 (17): 5526–5531.
Published: 18 September 2003
View article titled, CD10 Is a Key Enzyme Involved in the Activation of Tumor-activated Peptide Prodrug CPI-0004Na and Novel Analogues: Implications for the Design of Novel Peptide Prodrugs for the Therapy of CD10<sup>+</sup> Tumors
Open the PDF for CD10 Is a Key Enzyme Involved in the Activation of Tumor-activated Peptide Prodrug CPI-0004Na and Novel Analogues: Implications for the Design of Novel Peptide Prodrugs for the Therapy of CD10<sup>+</sup> Tumors in another window
Journal Articles

Comparative Metabolism and Retention of Iodine-125, Yttrium-90, and Indium-111 Radioimmunoconjugates by Cancer Cells

Oliver W. Press, Daming Shan, Janet Howell-Clark, Janet Eary, Frederick R. Appelbaum, Dana Matthews, David J. King, Adria M. R. Haines, Philip Hamann, Lois Hinman, Daniel Shochat, Irwin D. Bernstein
Journal: Cancer Research
Cancer Res (1996) 56 (9): 2123–2129.
Published: 01 May 1996
View article titled, Comparative Metabolism and Retention of Iodine-125, Yttrium-90, and Indium-111 Radioimmunoconjugates by Cancer Cells
Open the PDF for Comparative Metabolism and Retention of Iodine-125, Yttrium-90, and Indium-111 Radioimmunoconjugates by Cancer Cells in another window
Journal Articles

Improved Tumor Targeting with Chemically Cross-Linked Recombinant Antibody Fragments

David J. King, Alison Turner, Andrew P. H. Farnsworth, John R. Adair, Raymond J. Owens, R. Barbara Pedley, Darren Baldock, Karen A. Proudfoot, Alastair D. G. Lawson, Nigel R. A. Beeley, Kenny Millar, T. Andrew Millican, Byron A. Boyce, Pari Antoniw, Andrew Mountain, Richard H. J. Begent, Dan Shochat, Geoffrey T. Yarranton
Journal: Cancer Research
Cancer Res (1994) 54 (23): 6176–6185.
Published: 01 December 1994
View article titled, Improved Tumor Targeting with Chemically Cross-Linked Recombinant Antibody Fragments
Open the PDF for Improved Tumor Targeting with Chemically Cross-Linked Recombinant Antibody Fragments in another window